2.44
price down icon0.41%   -0.01
after-market Handel nachbörslich: 2.46 0.02 +0.82%
loading
Schlusskurs vom Vortag:
$2.45
Offen:
$2.46
24-Stunden-Volumen:
7.11M
Relative Volume:
0.75
Marktkapitalisierung:
$2.31B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.5155
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-2.79%
1M Leistung:
-10.62%
6M Leistung:
-2.79%
1J Leistung:
-31.27%
1-Tages-Spanne:
Value
$2.42
$2.50
1-Wochen-Bereich:
Value
$2.40
$2.67
52-Wochen-Spanne:
Value
$1.83
$7.48

Immunitybio Inc Stock (IBRX) Company Profile

Name
Firmenname
Immunitybio Inc
Name
Telefon
(844) 696-5235
Name
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
Mitarbeiter
685
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
IBRX's Discussions on Twitter

Vergleichen Sie IBRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBRX
Immunitybio Inc
2.44 2.32B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-20 Hochstufung Piper Sandler Neutral → Overweight
2025-03-06 Eingeleitet H.C. Wainwright Buy
2025-01-10 Eingeleitet BTIG Research Buy
2023-05-12 Herabstufung Piper Sandler Overweight → Neutral
2022-08-03 Eingeleitet Jefferies Buy

Immunitybio Inc Aktie (IBRX) Neueste Nachrichten

pulisher
06:57 AM

What drives ImmunityBio Inc stock priceMarket Sentiment Extremes & Exceptional Capital Investment - earlytimes.in

06:57 AM
pulisher
06:54 AM

Applying big data sentiment scoring on ImmunityBio Inc.July 2025 Action & Daily Growth Stock Investment Tips - newser.com

06:54 AM
pulisher
07:37 AM

Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionWeekly Trade Analysis & Safe Entry Point Identification - newser.com

07:37 AM
pulisher
06:55 AM

Will ImmunityBio Inc. rebound enough to break even2025 Dividend Review & Growth-Oriented Investment Plans - newser.com

06:55 AM
pulisher
Oct 20, 2025

ImmunityBio Inc. stock retracement – recovery analysisOptions Play & Scalable Portfolio Growth Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

ImmunityBio Inc. stock trend outlook and recovery path2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 12:10:55 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pickShare Buyback & Community Consensus Trade Alerts - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Tick level data insight on ImmunityBio Inc. volatilityQuarterly Trade Report & Precise Buy Zone Tips - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Short interest data insights for ImmunityBio Inc.Trade Entry Report & Fast Moving Trade Plans - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st

Oct 17, 2025
pulisher
Oct 16, 2025

Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Oct 16, 2025
pulisher
Oct 15, 2025

Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

ImmunityBio, Inc. (IBRX): Investor Outlook With A 311% Potential Upside - DirectorsTalk Interviews

Oct 14, 2025
pulisher
Oct 13, 2025

How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent

Oct 11, 2025
pulisher
Oct 11, 2025

Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo

Oct 10, 2025
pulisher
Oct 09, 2025

Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews

Oct 09, 2025
pulisher
Oct 08, 2025

IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan

Oct 08, 2025
pulisher
Oct 06, 2025

Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com

Oct 05, 2025

Finanzdaten der Immunitybio Inc-Aktie (IBRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
Kapitalisierung:     |  Volumen (24h):